ARCHIVES

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

This article is from The Cancer Letter archive.

Vol. 02 No. 41 | October 8, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

May 21, 2004

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990